Prism Medico & Pharmacy Limited has filed its confirmation certificate under SEBI Depositories Regulations for the quarter ended December 31, 2025. The company submitted the mandatory compliance document to BSE Limited and Metropolitan Stock Exchange of India Limited (MSEI) on January 14, 2026.

Regulatory Compliance Filing

The submission was made pursuant to Regulation 74(5) of Securities and Exchange Board of India (Depositories and Participants) Regulations, 2018. The confirmation certificate was issued by the company's Registrar and Share Transfer Agent, Purva Sharegistry (I) Pvt. Ltd., dated January 3, 2026.

Share Dematerialisation Activity

The certificate confirms that no dematerialisation activity took place during the Q3FY26 quarter. The detailed report shows nil entries across all parameters including folio numbers, shareholder names, certificate numbers, distinctive numbers, and shares dematerialised.

Company Information

Prism Medico and Pharmacy Limited is incorporated under CIN L24100HP2002PLC009299 with its registered office located at Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh. The company trades on BSE with scrip code 512217 and on MSEI with symbol PRISMMEDI under ISIN INE730E01016.

RTA Confirmation

Purva Sharegistry (I) Pvt. Ltd., the company's SEBI-registered Category 1 Registrar and Share Transfer Agent (Registration No. INR000001112), confirmed compliance with all regulatory requirements. The RTA verified that securities received for dematerialisation were processed within prescribed timelines and that depositories were substituted as registered owners in the member register as required.

Prism Medico & Pharmacy recently reported its financial results for the quarter ended September 30, revealing a mixed performance with a quarterly loss despite a profitable half-year. The company also addressed a filing error by re-uploading its complete financial statements to stock exchanges.

Financial Performance

For the quarter ended September 30, Prism Medico reported:

The company's revenue saw a significant decline of 68.75% compared to the previous quarter. This sharp decrease in revenue contributed to the quarterly loss of ₹0.10 crore, contrasting with a profit of ₹0.70 crore in the preceding quarter.

Half-Year Performance

Despite the weak quarterly results, Prism Medico's half-year performance shows some resilience:

• Half-year profit: ₹57.25 lakh
• This positive half-year result was primarily driven by the strong performance in the first quarter of the fiscal year.

Operating Efficiency

The company's operating profit margin (OPM) for the quarter stood at -20.00%, a substantial decline from 40.88% in the previous quarter. This negative margin indicates challenges in maintaining profitability amid declining revenues.

Filing Correction

Prism Medico addressed an inadvertent omission in its original financial statement filing to stock exchanges. The company re-uploaded the complete set of financial statements, including the Statement of Assets and Liabilities and Cash Flow Statement, which were initially missing from the PDF file. This correction ensures compliance with regulatory requirements and provides investors with comprehensive financial information.

Outlook

While the company faces short-term challenges as evidenced by the quarterly loss and revenue decline, the positive half-year profit suggests some underlying strength. Management's strategies to address the revenue decline and improve operational efficiency may be crucial for the company's performance in the remainder of the fiscal year.